
- Home
- Export
Export
Darnytsia is one of the largest pharmaceutical manufacturers in Ukraine, with production facilities certified according to GMP standards. We offer international partners various formats of cooperation: distribution/exclusive distribution of finished products, private label manufacturing, contract manufacturing, hospital sales and tender participation, technology transfer, and licensing models.
Countries that already have access to our products
- Asia-Pacific region
- Australia
- Europe
- Bosnia & Herzegovina,
- Lithuania,
- Poland,
- Moldova,
- Netherlands,
- Estonia
- MENA
- Iraq,
- Yemen,
- Libya
- Asia and the Caucasus
- Azerbaijan,
- Armenia,
- Georgia,
- Kazakhstan,
- Kyrgyzstan,
- Mongolia,
- Tajikistan,
- Turkmenistan,
- Uzbekistan
- 2025-2027Планові
- United Kingdom,
- Serbia,
- Croatia,
- Saudi Arabia,
- Botswana,
- Zimbabwe,
- Zambia,
- Namibia,
- South Africa,
- Israel,
- Vietnam,
- Malaysia,
- New Zealand,
- Singapore,
- Hong Kong SAR China,
- Latvia,
- North Macedonia
- EU, CIS, Latam
- Tetiana Kovtunenko
- [email protected]
- EU, CIS
- Liudmyla Makharin
- [email protected]
- Africa and international tenders
- Andrii Mashyna
- [email protected]
- MENA, ASIA
- Anna Stupak
- [email protected]

A brief overview of Darnytsia, including its production scale, market presence, and strategic directions.Company Presentation

Comprehensive list of products available for export collaborationProduct List
Export news
21 August 2025 Darnytsia Medicines Conquer the World: Ukrainian Quality on the Global Map of Health07 July 2025 Ukrainian Medicines Without Borders: In Six Months, Darnytsia Submitted 10 Medicines for Registration in 7 Countries Worldwide02 July 2025 Darnytsia Receives Lithuania’s GMP Certificate: The Quality of Ukrainian Medicines Recognized by Europe25 June 2025 Darnytsia Once Again Proves: Ukrainian Medicines Are Of World-Class Quality28 April 2025 Darnytsia Passed the Inspection of the Lithuanian State Medicines Control Agency for Compliance With International GMP Standards and the Requirements of This Country01 April 2025 Darnytsia Registered a Medicine for the Treatment of Headache and Migraine in Georgia26 March 2025 Darnytsia Wins International Tender and Gains the Right to Supply Medicines to 80 Countries Worldwide22 January 2025 In 2024, Darnytsia Registered 10 Medicines Abroad and Entered Six New Markets